Did you know Exxon Mobil returned over $32 billion to shareholders in just one year through stock buybacks? That’s a huge number, and it says a lot about how the company is using its profits.
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
We see Eli Lilly making waves with its bold decision to raise its 2025 sales guidance to $60 billion to $62 billion. This comes after a stellar second quarter, where revenue hit $15.56 billion, thanks to soaring sales of Mounjaro and Zepbound. For the stock market, this signals a bright future, though not without some…
Intraday update on DMN stock at $0.0017 on NASDAQ with heavy volume and Meyka AI grade B
Intraday update on PATH stock at $14.42 with Meyka AI forecast, grade and price targets
Intraday CGNX stock: Cognex at $39.61, PE 61.11, consensus target $45.64, Meyka forecast shows short-term downside
SYM stock pre-market 09 Mar 2026 at $48.61; analysis, Meyka AI forecast and price targets for this AI automation name
Pre-market CYXT stock: Cyxtera at $0.065 (NASDAQ) with volume 369,807,727 and Meyka AI model +53.85% outlook